Stability of nitric oxide in stored exhaled gases of healthy individuals

被引:0
|
作者
Chhibber, AK
Lustik, SJ
OHare, E
机构
来源
ACP-APPLIED CARDIOPULMONARY PATHOPHYSIOLOGY | 1996年 / 6卷 / 04期
关键词
exhaled gases; nitric oxide; stored gases; ventilation;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nitric oxide (NO), a highly reactive gas, is formed by cleavage of the guanido group on arginine. NO plays an important role in many pathophysiological processes. NO has been observed in the exhaled gases in normal humans and animals. Measurement of exhaled NO levels may be useful in the clinical management of diseases including asthma and chronic obstructive pulmonary disease. No data are available regarding the stability of NO in stored exhaled gases. This study was designed to determine, in healthy individuals, the stability of NO in exhaled gases stored for up to 24 hours in a balloon. After Institutional Review Board (IRE) approval, nitric oxide levels were measured both directly and in stored samples of exhaled gases of 15 healthy individuals using a chemiluminescence analyzer. Data were analyzed using repeated analysis of variance (ANOVA) and plotted using the Bland and Altman technique. NO levels measured when exhaled directly into the NO analyzer were 10.1 +/- 2.0 parts per billion (ppb). NO levels when measured in stored exhaled gases at two minutes, two hours, six hours, 12 hours and 24 hours after sample collection were 9.8 +/- 2.0, 10.0 +/- 2.0, 9.9 +/- 1.9, 9.8 +/- 1.9 and 10.2 +/- 2.1 ppb respectively There was no statistically significant difference between NO levels measured directly into the NO analyzer and levels measured over 24 hours in stored samples. The mean difference between NO levels when exhaled directly into the analyzer and two min, two hours, six hours, 12 hours and 24 hours after collection of exhaled gas samples were: 0.13 +/- 0.27, 0.04 +/- 0.24, 0.04 +/- 0.20, 0.13 +/- 0.23, and 0.02 +/- 0.57 ppb respectively. The 95% confidence intervals of the difference of NO levels measured directly into the analyzer and analyzed at 2 min, 2, 6, 12 and 24 hours were -0.41 to 0.67, -0.46 to 0.41, -0.35 to 0.45, -0.33 to 0.59 and -1.16 to 1.12 ppb respectively.
引用
收藏
页码:283 / 286
页数:4
相关论文
共 50 条
  • [41] Exhaled nitric oxide and COPD
    Taylor, D. R.
    Dummer, J.
    EUROPEAN RESPIRATORY JOURNAL, 2010, 36 (03) : 692 - 692
  • [42] Exhaled nitric oxide and asthma
    Currie, GP
    Lee, DKC
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (07): : 733 - 733
  • [43] Nitric oxide in exhaled air
    Lundberg, JON
    Weitzberg, E
    Lundberg, JM
    Alving, K
    EUROPEAN RESPIRATORY JOURNAL, 1996, 9 (12) : 2671 - 2680
  • [44] Exhaled Nitric Oxide in COPD
    Bikov, Andras
    Meszaros, Martina
    Lazar, Zsofia
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2019, 15 (02) : 71 - 78
  • [45] Measurement of Exhaled Nitric Oxide
    Oguzulgen, I. Kivilcim
    TURKISH THORACIC JOURNAL, 2013, 14 : 37 - 40
  • [46] Inhaled and exhaled nitric oxide
    B. Thébaud
    J.-F. Arnal
    J. C. Mercier
    A.-T. Dinh-Xuan
    Cellular and Molecular Life Sciences CMLS, 1999, 55 : 1103 - 1112
  • [47] Exhaled nitric oxide and atopy
    Gratziou, C
    DISEASE MARKERS IN EXHALED BREATH: BASIC MECHANISMS AND CLINICAL APPLICATIONS, 2002, 346 : 191 - 195
  • [48] Caffeine and exhaled nitric oxide
    Thomas, PS
    Yates, DH
    Bruce, C
    THORAX, 2003, 58 (03) : 281 - 281
  • [49] Exhaled nitric oxide and atherosclerosis
    Salonen, Iiris
    Huttunen, Kati
    Hirvonen, Maija-Riitta
    Dufva, Juhani
    Groundstroem, Kaj
    Dufva, Hilkka
    Salonen, Raimo O.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2012, 42 (08) : 873 - 880
  • [50] Exhaled nitric oxide in sarcoidosis
    Wilsher, ML
    Fergusson, W
    Milne, D
    Wells, AU
    THORAX, 2005, 60 (11) : 967 - 970